Focused on accelerating the development of cancer treatment through public-private partnerships, the University of Virginia Cancer Center Technology Partnership Initiative funds research collaborations between U.Va. cancer researchers and Virginia-based technology companies at the $50,000 to $150,000 level.
These collaborations could mean improved access to care for Virginia patients and the creation of new job opportunities within the state.
Funded projects in 2012 include the following:
U.Va. surgeon Dr. Todd W. Bauer and biomedical engineer Kimberly A. Kelly are working in partnership with Charlottesville-based biotechnology firm iTi Health Inc. to develop a molecular-based imaging technique to detect liver metastases in pancreatic cancer.
U.Va. neurologist Dr. Benjamin Purow is partnering with Reston-based nanopharmaceutical company Parabon NanoLabs Inc. to produce and test nano-pharmaceutical P25+Gd as a “plug-and-play” drug for simultaneous treatment and real-time monitoring of glioblastoma multiforme, or brain cancer.
U.Va.’s Mark B. Williams – professor of radiology and medical imaging, biomedical engineering and physics – and surgeon Dr. Craig L. Slingluff Jr. are partnering with the Newport News-based Jefferson Lab and Dilon Technologies Inc. to improve the speed and accuracy of cancer surgical procedures through the development of advanced imaging tools. The researchers seek to develop a tool for three-dimensional imaging using a new hand-held gamma camera and freehand SPECT, or single photon emission computed tomography.